Literature DB >> 7359975

The prognostic significance of metastatic cervical lymph nodes.

D E Schuller, W F McGuirt, B F McCabe, D Young.   

Abstract

The ability to predict accurately the clinical course of a patient with a malignancy is critically important to the patient's subsequent management. It has been well documented that the presence of metastatic nodal disease is associated with decreased patient survival. Survival data from a group of 242 head and neck cancer patients from the University of Iowa were analyzed to determine the significance of specific characteristics of metastatic lymph nodes. Evaluation of absolute numbers and percentages of positive nodes or node size generally was not useful. However, involvement of the posterior triangle nodes, noncontiguous nodal sites, or multiple sites was associated with a worse prognosis. When that was accurate enough to be of help to the clinician in prognostication. The single most important feature seems to be documentation of the presence of metastatic nodal disease, rather than particular features (i.e., number, size) of the metastatic nodes.

Entities:  

Mesh:

Year:  1980        PMID: 7359975     DOI: 10.1288/00005537-198004000-00001

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  16 in total

Review 1.  Management of cervical metastasis.

Authors:  Eric J Lentsch
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

2.  Clinical experiences with surgical therapy of cervical metastases from head and neck cancer.

Authors:  E de Campora; M Radici; A Camaioni; C Pianelli
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

Review 3.  Principles and techniques of irradiation for the N0 neck.

Authors:  F Eschwege; A Bridier; B Luboinski
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

4.  Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.

Authors:  Shlomo A Koyfman; Nofisat Ismaila; Doug Crook; Anil D'Cruz; Cristina P Rodriguez; David J Sher; Damian Silbermins; Erich M Sturgis; Terance T Tsue; Jared Weiss; Sue S Yom; F Christopher Holsinger
Journal:  J Clin Oncol       Date:  2019-02-27       Impact factor: 44.544

5.  Muscle invasion in oral tongue squamous cell carcinoma as a predictor of nodal status and local recurrence: just as effective as depth of invasion?

Authors:  Katherine Chandler; Courtney Vance; Steven Budnick; Susan Muller
Journal:  Head Neck Pathol       Date:  2011-09-04

6.  Efficacy of Single Transverse Neck Incision for Modified Radical Neck Dissection.

Authors:  Dushyant Mandlik; Ashutosh Vatsyayan; Priyanka Raina; Purvi Patel; Parin Patel; Nitin Sharma; Mitesh Patel; Sushen Bhatt; Shrinal Mankiwala; Daxesh Patel; Kaustubh Patel
Journal:  J Maxillofac Oral Surg       Date:  2019-07-26

7.  Immunohistochemistry, a valuable tool in detection of cervical lymph node micrometastases in head and neck squamous cell carcinoma: a prospective study.

Authors:  Anjani Kumar Sharma; Prakash Mishra; Shubha Gupta
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-03-27

8.  Occult node metastases in head and neck squamous carcinoma.

Authors:  A S Jones; D E Phillips; T R Helliwell; N J Roland
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

9.  Histopathological Definitions of Extranodal Extension: A Systematic Review.

Authors:  Chadi Nimeh Abdel-Halim; Tine Rosenberg; Stine Rosenkilde Larsen; Poul Flemming Høilund-Carlsen; Jens Ahm Sørensen; Max Rohde; Christian Godballe
Journal:  Head Neck Pathol       Date:  2020-09-12

10.  Metastatic and sentinel lymph node mapping using intravenously delivered Panitumumab-IRDye800CW.

Authors:  Giri Krishnan; Nynke S van den Berg; Naoki Nishio; Georgina Juniper; Jaqueline Pei; Quan Zhou; Guolan Lu; Yu-Jin Lee; Kimberly Ramos; Andrei H Iagaru; Fred M Baik; Alexander D Colevas; Brock A Martin; Eben L Rosenthal
Journal:  Theranostics       Date:  2021-05-24       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.